Stock Markets Analysis & Opinion

Shares of Facebook (NASDAQ:FB) were down nearly 3% in morning trading Thursday as concerns over the company’s plans to spend more cash outweighed its solid earnings results. Nevertheless, the...

Sellers returned yesterday, but it wasn't anything too damaging. The Russell 2000 had attempted a 'bull flag' breakout but was rebuffed. It fell back inside the consolidation, close to Tuesday's lows....

The Answer May Surprise You…Market volatility has been a hot topic this year, largely due to its historic lack of activity while staying at record-setting low levels as measured by the VIX...

Horizon Pharma plc (NASDAQ:HZNP) is scheduled to report third-quarter 2017 results before the opening bell on Nov 6. Last quarter, the company missed expectations by 16%. Let’s see how things...

The rally in DAX from 8/29 low is unfolding as a double three Elliott Wave structure where Intermediate wave (W) ended at 13089 and pullback to 12903 ended Intermediate wave (X).Up from there, the...

The current Fed Chair Janet Yellen’s four-year term ends in February and all eyes are now on the next likely takers of the seat. The Wall Street Journal reported on Wednesday, mentioning...

Retail real estate investment trust (REIT) Taubman Centers Inc. (NYSE:TCO) reported third-quarter 2017 adjusted funds from operations (FFO) per share of 83 cents, which missed the Zacks Consensus...

Quanta Services Inc. (NYSE:PWR) reported third-quarter 2017 adjusted earnings of 63 cents per share, surpassing the Zacks Consensus Estimate of 59 cents by 6.8%.The company’s GAAP earnings...

Immune Design Corp. (NASDAQ:IMDZ) reported loss of 52 cents per share in the third-quarter 2017, narrower than the Zacks Consensus Estimate of a loss of 63 cents and also a year-ago loss of 60...

Epizyme, Inc. (NASDAQ:EPZM) reported a loss of 63 cents per share in the third quarter of 2017, narrower than the Zacks Consensus Estimate of a loss of 65 cents but wider than the year-ago loss of...

The AES Corporation’s (NYSE:AES) third-quarter 2017 adjusted earnings per share of 24 cents missed the Zacks Consensus Estimate of 29 cents by 17.2%. Moreover, the bottom line declined 25%...

Clovis Oncology, Inc. (NASDAQ:CLVS) incurred third-quarter 2017 loss of $1.24 per share, which was narrower than the year-ago loss of $1.70 per share. However, the reported figure was wider than the...

Yum! Brands, Inc. (NYSE:YUM) posted better-than-expected third-quarter 2017 results with both earnings and revenues surpassing the Zacks Consensus Estimate.Earnings and Revenue DiscussionAdjusted...

Groupon Inc. (NASDAQ:GRPN) reported non-GAAP third-quarter 2017 earnings of 1 cent per share. The figure was in line with the Zacks Consensus Estimate.Revenues of $634.5 million declined 8% on a...